title: Cetuximab-associated folliculitis predominantly affecting the lower limbs.
authors.forename: Patrick A
authors.initials: PA
authors.lastname: Oberholzer
authors.forename: Luca
authors.initials: L
authors.lastname: Borradori
authors.forename: Helmut
authors.initials: H
authors.lastname: Beltraminelli
mesh_terms: D000230:Adenocarcinoma / Q000188:drug therapy / Q000473:pathology / Q000601:surgery; D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000009:adverse effects*; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use; D000068818:Cetuximab; D017024:Chemotherapy, Adjuvant; D003110:Colonic Neoplasms / Q000188:drug therapy / Q000473:pathology / Q000601:surgery; D018450:Disease Progression; D003875:Drug Eruptions / Q000175:diagnosis*; D017809:Fatal Outcome; D005499:Folliculitis / Q000139:chemically induced* / Q000175:diagnosis; D006801:Humans; D007868:Leg Dermatoses / Q000139:chemically induced* / Q000175:diagnosis; D008207:Lymphatic Metastasis / Q000473:pathology; D008297:Male; D008875:Middle Aged
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents; D000068818:Cetuximab